129 related articles for article (PubMed ID: 9345654)
1. New insulins and other possible therapeutic approaches.
Johannesen J; Petersen KF; Berger M; Binder C
Diabetologia; 1997 Oct; 40 Suppl 3():B89-93. PubMed ID: 9345654
[No Abstract] [Full Text] [Related]
2. American Diabetes Association--63rd Scientific Sessions. Clinical data. 13-17 June 2003, New Orleans, LA, USA.
Evans L
IDrugs; 2003 Aug; 6(8):723-4. PubMed ID: 12971382
[No Abstract] [Full Text] [Related]
3. Insulin analogues in children and teens with type 1 diabetes: advantages and caveats.
Rachmiel M; Perlman K; Daneman D
Pediatr Clin North Am; 2005 Dec; 52(6):1651-75. PubMed ID: 16301087
[TBL] [Abstract][Full Text] [Related]
4. Is pramlintide an adjunct to insulin therapy?
Charles MA
Diabetes Technol Ther; 2002; 4(2):190-2. PubMed ID: 12079622
[No Abstract] [Full Text] [Related]
5. Improvements and new potentials in pharmacological therapy of diabetes mellitus in children and adolescents.
Kiess W; Kapellen T; Siebler T; Dost A; Deutscher J; Nietzschmann U
Horm Res; 1998; 50 Suppl 1():87-90. PubMed ID: 9677006
[TBL] [Abstract][Full Text] [Related]
6. Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.
Dunn CJ; Plosker GL
Pharmacoeconomics; 2002; 20(14):989-1025. PubMed ID: 12403639
[TBL] [Abstract][Full Text] [Related]
7. New treatments of diabetes: the beta-amylin agonists.
Lebovitz HE
Ann Endocrinol (Paris); 2008 Apr; 69(2):147-50. PubMed ID: 18423421
[No Abstract] [Full Text] [Related]
8. Pharmacologic management of type 1 diabetes: a review for dentistry.
Little JW; Rhodus NL
Gen Dent; 2007; 55(5):403-9. PubMed ID: 17899716
[TBL] [Abstract][Full Text] [Related]
9. On calculating treatment satisfaction.
Bradley C
Diabetes Care; 1999 Oct; 22(10):1760. PubMed ID: 10526762
[No Abstract] [Full Text] [Related]
10. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
Maggs DG; Fineman M; Kornstein J; Burrell T; Schwartz S; Wang Y; Ruggles JA; Kolterman OG; Weyer C
Diabetes Metab Res Rev; 2004; 20(1):55-60. PubMed ID: 14737746
[TBL] [Abstract][Full Text] [Related]
11. Mixing insulin lispro and ultralente insulin.
Bastyr EJ; Holcombe JH; Anderson JH; Clore JN
Diabetes Care; 1997 Jun; 20(6):1047-8. PubMed ID: 9167130
[No Abstract] [Full Text] [Related]
12. Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients.
Rave K; Heinemann L; Puhl L; Gudat U; Woodworth JR; Weyer C; Heise T
Diabetes Care; 1999 May; 22(5):865-6. PubMed ID: 10332707
[No Abstract] [Full Text] [Related]
13. Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?
Edelman SV; Garg S; Kolterman OG
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):E1; discussion E2. PubMed ID: 17452962
[No Abstract] [Full Text] [Related]
14. Reducing mistakes in patient administration of glargine and lispro.
Schutta MH
Diabetes Care; 2002 Jun; 25(6):1098-9. PubMed ID: 12032124
[No Abstract] [Full Text] [Related]
15. New diabetes drug.
FDA Consum; 2005; 39(3):3. PubMed ID: 16130200
[No Abstract] [Full Text] [Related]
16. Designer insulins: moving closer to convenient and physiological replacement of insulin.
Boyages SC
Med J Aust; 1999 Apr; 170(8):349-50. PubMed ID: 10327943
[No Abstract] [Full Text] [Related]
17. Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.
Weyer C; Gottlieb A; Kim DD; Lutz K; Schwartz S; Gutierrez M; Wang Y; Ruggles JA; Kolterman OG; Maggs DG
Diabetes Care; 2003 Nov; 26(11):3074-9. PubMed ID: 14578242
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of insulin allergy in a 1-year-old infant with neonatal diabetes by lispro and glargine insulin.
Kara C; Kutlu AO; Evliyaoglu O; Bilgili H; Yildirim N
Diabetes Care; 2005 Apr; 28(4):983-4. PubMed ID: 15793215
[No Abstract] [Full Text] [Related]
19. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.
Attia N; Jones TW; Holcombe J; Tamborlane WV
Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247
[TBL] [Abstract][Full Text] [Related]
20. Impact on clinical status and quality of life of switching from regular insulin to insulin lispro among patients using insulin pumps.
Campbell RK; Sclar DA; Robison LM; Stowers JK; Ferguson JC; Trippe BS; Kayne DM
Diabetes Educ; 1998; 24(1):95-9. PubMed ID: 9526330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
